Not for use in diagnosing, treating, curing, mitigating, or preventing any disease or medical condition
USA 110 , E766E775 (2013)
Why women need a female-specific retatrutide dosing approach Pharmacokinetics differ by sex The assumption that one dose fits all has caused real harm in weight-loss pharmacology
Gastrointestinal disturbances may be attributed to semaglutide delaying gastric emptying, in conjunction with affecting gastric inhibitory polypeptide levels
Glycosuria contributes directly to improved glycemic control, while increased distal sodium delivery restores normal tubuloglomerular feedback, thereby lowering intraglomerular pressure, which is a key mechanism in slowing DKD progression [25,27]